Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Humana Walmart Part D Plan Expected To Boost PDP Membership To 2.4 Mil. In 2011

This article was originally published in The Pink Sheet Daily

Executive Summary

2011 enrollment in the new stand-alone Medicare prescription drug plan co-marketed by Humana and Walmart has "significantly exceeded expectations," the insurer reports.

You may also be interested in...



Humana Weighing Drug Purchasing Change With PBM “Strategic Review”

The insurer is considering strategic options for its internal PBM, which manages more than 300 million drug claims for more than 9 million individuals, mainly in the Medicare space.

Growth Through Part D: CVS Caremark May Be Second Leading PDP Sponsor With UA Purchase

CVS Caremark will more than double its Part D business with the acquisition of the Community CCRx plans from Universal American.

Humana Walmart PDP May Drive Tougher Contracting By Retailers, Drug Plans

The new Medicare prescription drug plan being introduced jointly by Humana and Walmart for 2011 is dramatically less expensive than anything else in the Part D market and seems certain to prompt more intense scrutiny of drug costs among competing retailers and plans.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS071912

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel